新肝移植患者使用新山地明与环孢素维持治疗的经济学评估：一项国际随机对照试验的结果。米尔顿研究小组。 - Suppr | 超能文献

Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.

作者信息

Peeters P, Kazek M, Abella I, Noble I

机构信息

Lewin Group, Paris, France.

出版信息

Transplant Proc. 1998 Aug;30(5):1838-42. doi: 10.1016/s0041-1345(98)00450-3.

DOI:10.1016/s0041-1345(98)00450-3

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Economic evaluation of Neoral versus Sandimmune maintenance therapy for de novo liver transplant patients: results from an International Randomized Controlled Trial. Milton Study Group.新肝移植患者使用新山地明与环孢素维持治疗的经济学评估：一项国际随机对照试验的结果。米尔顿研究小组。

Transplant Proc. 1998 Aug;30(5):1838-42. doi: 10.1016/s0041-1345(98)00450-3.

2

Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.肝移植受者中赛尼哌与新山地明的长期耐受性、药效学及安全性比较。安大略肝移植研究组

Transplant Proc. 1996 Aug;28(4):2232-3.

3

Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.稳定期肝移植患者从传统环孢素制剂（山地明）转换为新型口服微乳剂（新山地明）的情况。

Transplant Proc. 1998 Aug;30(5):1857. doi: 10.1016/s0041-1345(98)00458-8.

4

Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.病例研究：一名肝移植患者从环孢素山地明转换为新山地明。

Transplant Proc. 1996 Aug;28(4):2252-3.

5

Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.采用以新山地明为基础的双重免疫抑制方案后肝移植急性排斥反应减少。

Transplant Proc. 1998 Aug;30(5):1855-6. doi: 10.1016/s0041-1345(98)00457-6.

6

Sandimmune Neoral in paediatric liver transplant recipients with malabsorption of cyclosporin A.新山地明（Sandimmune Neoral）用于环孢素A吸收不良的儿童肝移植受者。

Transplant Proc. 1994 Oct;26(5):2953-4.

7

Cost-effective management of acute rejection in liver transplant recipients: a managed care perspective.肝移植受者急性排斥反应的成本效益管理：管理式医疗视角

Transplant Proc. 1997 Feb-Mar;29(1-2):1557-9. doi: 10.1016/s0041-1345(96)00673-2.

8

Immunosuppressive therapy with microemulsion cyclosporine A shortens the hospitalization of pediatric liver transplant recipients.

Clin Transplant. 1998 Dec;12(6):588-92.

9

Cyclosporine Neoral in liver transplant recipients.肝移植受者使用新山地明（环孢素软胶囊）。

Transplant Proc. 1994 Oct;26(5):2949-52.

10

FK506 for primary and rescue therapy following liver transplantation.

Transplant Proc. 1998 Jun;30(4):1409-10. doi: 10.1016/s0041-1345(98)00293-0.

引用本文的文献

1

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述

Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.

2

Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.环孢素微乳剂（新山地明）。与标准环孢素相比，其在肾移植和肝移植中应用的药物经济学综述。

Pharmacoeconomics. 1998 Dec;14(6):691-708. doi: 10.2165/00019053-199814060-00009.